Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory Life Science
Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year Life Science
Alpine Immune Sciences Completes Sale of S-Nitrosoglutathione Reductase (GSNOR) Assets to Laurel Venture Capital Life Science